A 61-year-old woman with a 1-year history of hepatitis B liver cirrhosis (LC) was scheduled to undergo elective adult-to-adult living donor LT. In addition to LC, she was also diagnosed with diabetes mellitus. Preoperative transthoracic echocardiography indicated normal biventricular and valvular function, with a left ventricular ejection fraction (LVEF) of 71%. Abdominal and pelvic computed tomography showed a large amount of ascites and esophageal varix with a cirrhotic liver. The laboratory findings were not remarkable, except for the low platelet count (65,000/ dL), and slightly elevated aspartate transaminase levels (57 IU/L) and total bilirubin levels (2.5 mg/dL).
Editorial
Contrary to the previous belief that patients with chronic liver disease are at risk of bleeding, a procoagulant imbalance is believed to exist in chronic liver disease. [3] The possible clinical implications of this procoagulant imbalance include portal or peripheral vein thrombosis and arterial thrombosis. [6] [7] [8] [9] [10] Moreover, intraoperative thromboembolic events, such as pulmonary thromboembolism (PTE) as a result of bleeding due to coagulopathy, have become a major concern during LT for end-stage liver disease. [11, 12] In fact, the incidence of intraoperative PTE during adult LT ranges from 1.2% to 6.25%. [13, 14] In particular, Sakai et al. [15] reported 20 cases of intraoperative PTE during adult LT (4%) among 495
LTs. PTE occurred during the non-hepatic phase, particularly 30 min after graft reperfusion, in most cases.
Moreover, that study indicated that the PTE group had poorer outcomes than the non-PTE group in terms of patient survival and graft survival. These patients were treated with heparin infusion or thrombolytic agents, and none of the patients were receiving ECMO support.
In our present case, 10,000 units bolus of heparin was 
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